温红玲
+
Gender:Female
Paper Publications
- [31] 温红玲. High-throughput Screening and Identification of Human Adenovirus type 5 (HAdV-5) Inhibitors. Frontiers in Cellular and Infection Microbiology, section Virus and Host, 11, 1, 2021.
- [32] 褚福禄. Roles of conserved residues in the receptor binding sites of human parainfluenza virus type 3 HN protein. MICROBIAL PATHOGENESIS, 158, 2021.
- [33] 赵丽. HIV-1 Tat 蛋白对 U87 细胞活性及氧化应激的影响. 中华实验和临床病毒学杂志, 35, 34, 2021.
- [34] 赵丽. HAD 患者来源的 HIV-1 Nef 蛋白对U87细胞分泌TNF-α和IL-1β细胞因子的影响. 中华实验和临床病毒学杂志, 35, 241, 2021.
- [35] 许一菲. Frequent reassortment and potential recombination shape the genetic diversity of influenza D viruses. Journal of Infection, 82, E36, 2021.
- [36] 温红玲. SARS-CoV-2 Variant of Concern 202 012/01 (B.1.1.7)in a traveller from the UK to China. JOURNAL OF TRAVEL MEDICINE, 2021.
- [37] 温红玲. 肠道病毒71型EGFP标记重组病毒的构建与拯救. 中华实验和临床病毒学杂志, 2020.
- [38] 温红玲. 柯萨奇病毒A组2型的分离鉴定与系统进化分析. 中华实验和临床病毒学杂志, 2020.
- [39] 温红玲. 我国常见蜱传疾病的流行病学研究进展. 中华实验和临床病毒学杂志, 2020.
- [40] 温红玲. Identification of a novel HIV-1 second-generation Circulating Recombinant Form CRF109_0107 in China. International Journal of Infectious Diseases, 2020.